| Literature DB >> 25291160 |
Ioannis Dimarakis1, Stuart Grant1, Rebecca Corless2, Theodore Velissaris3, Martin Prince4, Ben Bridgewater1, George Asimakopoulos5.
Abstract
Increasing prevalence of hepatic disease is likely to translate in a growing number of patients with significant hepatic disease requiring cardiac surgery. Available cardiac risk stratification models do not address the risk associated with hepatic disease. However, weighted mean mortality rates based on previous studies of cardiac surgery in patients with hepatic disease demonstrate operative mortality rates that range from 9.88% (standard deviation [SD] 9.69) for patients in Child-Turcotte-Pugh (CTP) class A cirrhosis to 69.23% (SD 28.55) for patients with CTP class C cirrhosis. This review comprehensively appraises the pathophysiology of hepatic disease, reported clinical outcomes and considerations for risk stratification. Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Year: 2014 PMID: 25291160 DOI: 10.1055/s-0034-1389084
Source DB: PubMed Journal: Thorac Cardiovasc Surg ISSN: 0171-6425 Impact factor: 1.827